CYNOSURE PHOTOGENICA ER
K012790 · Cynosure, Inc. · GEX · Nov 16, 2001 · General, Plastic Surgery
Device Facts
| Record ID | K012790 |
| Device Name | CYNOSURE PHOTOGENICA ER |
| Applicant | Cynosure, Inc. |
| Product Code | GEX · General, Plastic Surgery |
| Decision Date | Nov 16, 2001 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 878.4810 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The PhotoGenica ER laser is used for skin resurfacing in the treatment of wrinkles and for the incision, excision ablation or vaporization of soft bodily tissues.
Device Story
PhotoGenica ER Laser is a medical laser system consisting of a power supply, water cooling system, and optical bench. It operates at 20 pulses per second with a pulse energy of 2 Joules, delivering 20 watts of average power. Used by clinicians in dermatology or plastic surgery settings for soft tissue procedures and skin resurfacing. The device functions by delivering laser energy to target tissues to achieve ablation or vaporization. The healthcare provider operates the system to perform surgical or cosmetic procedures, directly affecting tissue removal or skin texture improvement.
Clinical Evidence
No clinical data provided; no nonclinical performance data provided.
Technological Characteristics
Er:YAG laser system; 2.94 micron wavelength; 20 pulses per second; 2 Joules pulse energy; 20 watts average power. System comprises power supply, water cooling unit, and optical bench. Class II medical laser.
Indications for Use
Indicated for skin resurfacing to treat wrinkles and for incision, excision, ablation, or vaporization of soft bodily tissues.
Regulatory Classification
Identification
(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
Predicate Devices
- Continuum Biomedical CB Erbium / 2.94™ Er:YAG Laser
Related Devices
- K973498 — CYNOSURE PHOTOGENICA ER LASER · Cynosure, Inc. · Nov 13, 1997
- K961748 — MEDLITE/ERBIUM LASER SYSTEM · Continuum Biomedical, Inc. · Jul 26, 1996
- K964253 — DERMA 20 LASER SYSTEM · Esc Medical Systems , Ltd. · Apr 11, 1997
- K973576 — EPULSE MODEL 2940 ER:ASER ER:YAG LASER SYSTEM · Epulse Technologies, Inc. · Dec 9, 1997
- K983034 — CYNOSURE CO3 ER:YAG LASER · Cynosure, Inc. · Sep 10, 1998
Submission Summary (Full Text)
{0}------------------------------------------------
## 510(K) Summary
## NOV 1 6 2001
## k 012790
ﺴﺴﺴﺴﺴﺴﺴﺴ
| Submitter: | Cynosure, Inc.<br>10 Elizabeth Drive<br>Chelmsford, MA 01824 |
|-------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | George Cho<br>Senior Vice President of Medical Technology |
| Date Summary Prepared: | August 16, 2001 |
| Device Trade Name: | PhotoGenica ER Laser |
| Common Name: | Medical Laser System |
| Classification Name: | Instrument, surgical, powered, laser<br>79-GEX<br>21 CFR 878.48 |
| Equivalent Device: | Continuum Biomedical CB Erbium / 2.94™ Er:YAG Laser |
| Device Description: | The PhotoGenica ER Laser consists of three interconnected sections:<br>the power supply, the water cooling system and the optical bench. At<br>20 pulses per second and a pulse energy of 2 Joules, the average power<br>from the laser is 20 watts. |
| Intended Use: | Skin resurfacing in the treatment of wrinkles. |
| Comparison: | The PhotoGenica ER Laser is substantially equivalent to the<br>Continuum Biomedical CB Erbium / 2.94™ Er: YAG Laser in terms of<br>treatment wavelength, pulse duration, pulse energy, and biological<br>effects. |
| Nonclinical Performance Data: | none |
| Clinical Performance Data: | none |
| Conclusion: | The PhotoGenica ER Laser is another safe and effective way to<br>remove or reduce wrinkles, and to ablate or excise tissue. |
| Additional Information: | None requested at this time |
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around the perimeter. Inside the circle is an emblem that resembles an eagle with three stripes above its head.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. George Cho Senior Vice President of Medical Technology Cynosure, Inc. 10 Elizabeth Drive Chelmsford, Massachusetts 01824
Re: K012790
Trade/Device Name: PhotoGenica ER Laser Regulation Number: 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology. Regulatory Class: II Product Code: GEX Dated: August 16, 2001 Received: August 20, 2001
NOV 1 6 2001
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{2}------------------------------------------------
## Page 2 - Mr. George Cho
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis letter will and in yourse finding of substantial equivalence of your device to a legally promance holized device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). regaration entitives, which on your responsibilities under the Act may be obtained from the Oixision of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Walker, MD
Image /page/2/Picture/5 description: The image shows a close-up of a handwritten letter 'fa' in cursive. The letters are connected, with the 'f' extending upwards and looping over, and the 'a' following closely behind. The writing appears to be done with a pen or marker, and the ink is dark.
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and
Radiological Health
Enclosure
{3}------------------------------------------------
NOV 1 6 2001
Page Page of
510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________
Device Name: _ Cynosure PhotoGenica ER Laser
Indications For Use:
The PhotoGenica ER laser is used for skin resurfacing in the treatment of wrinkles and for the incision, excision ablation or vaporization of soft bodily tissues.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Walk, 17
(Division Sign-Off) Division of General, Restorative and Neurological Devices
Prescription Use
✓
510(k) Number 12012790
OR
Over-The-Counter Use_
(Optional Format 1-2-96)